Mirapex - MSN Newsfeeds
- Medical News Today - Pramipexole (known in Europe under the trade names Mirapexin® and Sifrol® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first approved in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson's ...
- Portsmouth Herald - Police said they searched her pocketbook and found two Mirapex pills, which are used for symptoms of restless leg syndrome. Szczuka was transported to Exeter Hospital for treatment and later taken back to the police station and held on $500 cash bail ...
- ABC News - She is now being treated with Mirapex, a dopamine agonist like Requip that has cured -- at least temporarily -- all her symptoms. "For the first time, I slept," Cardinale said. "I cried on the phone to the doctor, 'Thank you so much.' It's a miracle
- Newburyport Daily News - Mendes took Szczuka to Exeter Hospital for treatment after a search of her purse revealed two Mirapex pills, which treat restless legs syndrome. At Exeter, Szczuka was revived. It was then she told Mendes the amount and number of drugs she consumed ...
- HealthCentral.com - Pramipexole, usually sold under the brand name Mirapex, is a new dopamine receptor agonist, a drug that binds to and activates dopamine receptors. Dopamine receptors are Cell-surface proteins that bind dopamine with high affinity and trigger ...
- WXYZ - Other dopamine agonists include GlaxoSmithKline's Requip, or ropinirole, and Boehringer Ingelheim Pharmaceuticals, Inc.'s Mirapex, or pramipexole. Shares of Valeant closed up 2 cents at $17.13 on the New York Stock Exchange on Thursday. Shares of Par ...
- Detroit News - Eligible patients must have a confirmed case of the disease and take medications such as Sinemet, Requip or Mirapex, for at least nine months but no longer than two years, according to MSU. Investigators will measure disease progression by measuring ...
- ABC News - Sensations are often described as burning, creeping, tugging, or like insects crawling inside the legs. Doctors are now saying heavily advertized drugs like Requip and Mirapex can make symptoms even worse. They recommend rotating those drugs with ...
- Biloxi Sun Herald - Prescription drugs approved to treat this condition include ropinirole (Requip) and pramipexole (Mirapex), agents that enhance the activity of the neurotransmitter dopamine. Drug side effects can include nausea and vomiting, dizziness, drowsiness or ...
- ABC News - Sensations are often described as burning, creeping, tugging, or like insects crawling inside the legs. Doctors are now saying heavily advertized drugs like Requip and Mirapex can make symptoms even worse. They recommend rotating those drugs with ...
- CBS News - The two currently leading dopamine agonists, Mirapex and Requip, are oral drugs that are shown to do that." Unfortunately, patients on these drugs may begin to experience the on/off effect as well. It's been thought that this happens because oral ...
- FOX News - The two currently leading dopamine agonists, Mirapex and Requip, are oral drugs that are shown to do that." Unfortunately, patients on these drugs may begin to experience the on/off effect as well. It's been thought that this happens because oral ...
- innovations report - In the wake of FDA approval for Requip and Mirapex (pramipexole), along with the attendant heavy advertising, Kurlan and Richard stress the importance to both primary care physicians and patients alike of understanding the risks of relying on these ...
- American Family Physician - Pramipexole (Mirapex), Ropinirole (Requip) Nausea, sleep attacks, edema, hallucinations, hypotension Useful for early disease and in patients with Parkinson's disease and motor fluctuations MAO-B inhibitors Selegiline (Eldepryl) ...
- PR Newswire - RIDGEFIELD, Conn., Nov. 10 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex(R) (pramipexole dihydrochloride) tablets for the treatment of moderate-to ...
- Medical News Today - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licenced in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
- Phramalive.com - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licensed in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
- Phramalive.com - Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the U.S.A. as Mirapex®) is a compound from Boehringer Ingelheim research first licenced in 1997 for the treatment of the signs and symptoms of idiopathic Parkinson`s ...
- United Press International - Boehringer Ingelheim's Mirapex will lead the pack for a while, but it's also facing generic erosion in 2011 when its patent expires. That will open the doors for Schwarz, XenoPort and Serono. Schwarz's rotigotine CDS, which is expected to launch in ...
- Washington Post - When I was originally diagnosed I was put on another dopamine agonist, Mirapex, which worked well for about a month or so, then I had to increase the dosage to continue to get the benefits. And that would happen every couple of months. I increased to ...
Pages: 1 2 Next






